Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease
Authors:
- Seung U. KimSKSeung U. Kim
- James G. McLarnonJMJames G. McLarnon
- 1 May 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 187 (1) , 150-159
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Advanced glycation endproducts cause lipid peroxidation in the human neuronal cell line SH-SY5YJournal of Alzheimer’s Disease, 2003
- Altered neuronal nitric oxide synthase expression contributes to disease progression in Huntington’s disease transgenic miceBrain Research, 2002
- Increased oxidative damage to DNA in a transgenic mouse model of Huntington's diseaseJournal of Neurochemistry, 2001
- Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in miceNature Medicine, 2000
- Energetics in the pathogenesis of neurodegenerative diseasesTrends in Neurosciences, 2000
- Oxidative Stress in Huntington's DiseaseBrain Pathology, 1999
- Pyruvate Protects Neurons against Hydrogen Peroxide-Induced ToxicityThe Journal of Neuroscience, 1997
- Mechanisms of Reduced Striatal NMDA Excitotoxicity in Type I Nitric Oxide Synthase Knock-Out MiceJournal of Neuroscience, 1997
- Oxidative damage and metabolic dysfunction in Huntington's disease: Selective vulnerability of the basal gangliaAnnals of Neurology, 1997
- Replication of the neurochemical characteristics of Huntington's disease by quinolinic acidNature, 1986